Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
capsule, carryforward, case, category, CDx, companion, Daichii, diagnostic, diversity, efficiency, enable, enriched, epidermal, establishing, exposure, frame, geographic, imbalance, Japanese, made, modify, NDA, overlapping, Pharmacokinetic, plasma, PMA, potent, practice, predefined, Premarket, sorafenib, tablet, temporarily, trend
Removed:
adenosine, Administration, advance, AKIPTM, amendment, ATP, binding, CI, cohort, committed, competing, conducting, consent, consist, death, demonstrating, detail, discontinuation, energy, entirety, entity, experienced, experimental, Food, GAAP, gene, iii, inform, informed, investigating, investigator, involved, issuance, kinesin, leading, living, low, motor, mutated, Mutation, objective, offering, outflow, participating, physiological, produced, prolonged, pronounced, prospectively, RAF, reclassified, request, revised, secondary, SRC, suspend, systemic, triphosphate, TTP, United, variety, wild
Filing tables
Filing exhibits
Related press release
ARQL similar filings
Filing view
External links